Together our data support the notion that microbiota-driven IL-17+RORγt+ILC activation can promote increased immunopathology, thus further demonstrating the role that IL-17 plays in cutaneous leishmaniasis. This evidence concerns the gene CCL27 and cutaneous leishmaniasis.